• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 23 May

    Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers

    DehydraTECH-CBD offers distinctive mechanistic benefits related to its growing therapeutic utility KELOWNA, BC / ACCESSWIRE / May 23, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce additional findings from last year's human clinical study HYPER-H21-4 ("the Study")… Read More..

    Share this:
  • 23 May

    LiveOne to Acquire Certain Assets of Kast Media

    - Proposed Deal Expected to Add $10+ Million in Annual Revenues, Anticipated to be Accretive to LiveOne’s EBITDA and Revenues - Acquisition Would Bring In-House IP Development and Ownership to LiveOne and Its Subsidiaries and Expected to Include More Than 25 Weekly Podcasts and 33 Million Monthly Downloads - Assets… Read More..

    Share this:
  • 23 May

    SKYX Set to Join Russell 2000(R) and Russell 3000(R) Indexes

    MIAMI, FL / ACCESSWIRE / May 23, 2023 / SKYX Platforms Corp. (NASDAQ:SKYX) (d/b/a "Sky Technologies") SKYX, a highly disruptive platform technology company with over 60 issued and pending patents globally with a mission to make homes and buildings become safe and smart as the new standard, today announced that… Read More..

    Share this:
« Previous 1 … 149 150 151 152 153 … 240 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact